Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Gene Therapy in Oncology market report explains the definition, types, applications, major countries, and major players of the Gene Therapy in Oncology market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Shenzhen SiBiono GeneTech
Cold Genesys
Merck
Bio-Path Holdings
Marsala Biotech
Advantagene
Bristol-Myers Squibb
Ziopharm Oncology
CRISPR Therapeutics
UniQure
Tocagen
Amgen
Idera Pharmaceuticals
Oncosec
Intellia Therapeutics
AstraZeneca
Sillajen Biotherapeutics
Oncolytics Biotech
Johnson & Johnson
Editas Medicine
Mologen AG
Oncotelic
Geron Corp
By Type:
Ex Vivo
In Vivo
By End-User:
Hospitals
Diagnostics Centers
Research Institutes
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Gene Therapy in Oncology Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Gene Therapy in Oncology Outlook to 2028- Original Forecasts
-
2.2 Gene Therapy in Oncology Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Gene Therapy in Oncology Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Gene Therapy in Oncology Market- Recent Developments
-
6.1 Gene Therapy in Oncology Market News and Developments
-
6.2 Gene Therapy in Oncology Market Deals Landscape
7 Gene Therapy in Oncology Raw Materials and Cost Structure Analysis
-
7.1 Gene Therapy in Oncology Key Raw Materials
-
7.2 Gene Therapy in Oncology Price Trend of Key Raw Materials
-
7.3 Gene Therapy in Oncology Key Suppliers of Raw Materials
-
7.4 Gene Therapy in Oncology Market Concentration Rate of Raw Materials
-
7.5 Gene Therapy in Oncology Cost Structure Analysis
-
7.5.1 Gene Therapy in Oncology Raw Materials Analysis
-
7.5.2 Gene Therapy in Oncology Labor Cost Analysis
-
7.5.3 Gene Therapy in Oncology Manufacturing Expenses Analysis
8 Global Gene Therapy in Oncology Import and Export Analysis (Top 10 Countries)
-
8.1 Global Gene Therapy in Oncology Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Gene Therapy in Oncology Export by Region (Top 10 Countries) (2017-2028)
9 Global Gene Therapy in Oncology Market Outlook by Types and Applications to 2022
-
9.1 Global Gene Therapy in Oncology Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Ex Vivo Consumption and Growth Rate (2017-2022)
-
9.1.2 Global In Vivo Consumption and Growth Rate (2017-2022)
-
9.2 Global Gene Therapy in Oncology Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Diagnostics Centers Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Research Institutes Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Gene Therapy in Oncology Market Analysis and Outlook till 2022
-
10.1 Global Gene Therapy in Oncology Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Gene Therapy in Oncology Consumption (2017-2022)
-
10.2.2 Canada Gene Therapy in Oncology Consumption (2017-2022)
-
10.2.3 Mexico Gene Therapy in Oncology Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Gene Therapy in Oncology Consumption (2017-2022)
-
10.3.2 UK Gene Therapy in Oncology Consumption (2017-2022)
-
10.3.3 Spain Gene Therapy in Oncology Consumption (2017-2022)
-
10.3.4 Belgium Gene Therapy in Oncology Consumption (2017-2022)
-
10.3.5 France Gene Therapy in Oncology Consumption (2017-2022)
-
10.3.6 Italy Gene Therapy in Oncology Consumption (2017-2022)
-
10.3.7 Denmark Gene Therapy in Oncology Consumption (2017-2022)
-
10.3.8 Finland Gene Therapy in Oncology Consumption (2017-2022)
-
10.3.9 Norway Gene Therapy in Oncology Consumption (2017-2022)
-
10.3.10 Sweden Gene Therapy in Oncology Consumption (2017-2022)
-
10.3.11 Poland Gene Therapy in Oncology Consumption (2017-2022)
-
10.3.12 Russia Gene Therapy in Oncology Consumption (2017-2022)
-
10.3.13 Turkey Gene Therapy in Oncology Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Gene Therapy in Oncology Consumption (2017-2022)
-
10.4.2 Japan Gene Therapy in Oncology Consumption (2017-2022)
-
10.4.3 India Gene Therapy in Oncology Consumption (2017-2022)
-
10.4.4 South Korea Gene Therapy in Oncology Consumption (2017-2022)
-
10.4.5 Pakistan Gene Therapy in Oncology Consumption (2017-2022)
-
10.4.6 Bangladesh Gene Therapy in Oncology Consumption (2017-2022)
-
10.4.7 Indonesia Gene Therapy in Oncology Consumption (2017-2022)
-
10.4.8 Thailand Gene Therapy in Oncology Consumption (2017-2022)
-
10.4.9 Singapore Gene Therapy in Oncology Consumption (2017-2022)
-
10.4.10 Malaysia Gene Therapy in Oncology Consumption (2017-2022)
-
10.4.11 Philippines Gene Therapy in Oncology Consumption (2017-2022)
-
10.4.12 Vietnam Gene Therapy in Oncology Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Gene Therapy in Oncology Consumption (2017-2022)
-
10.5.2 Colombia Gene Therapy in Oncology Consumption (2017-2022)
-
10.5.3 Chile Gene Therapy in Oncology Consumption (2017-2022)
-
10.5.4 Argentina Gene Therapy in Oncology Consumption (2017-2022)
-
10.5.5 Venezuela Gene Therapy in Oncology Consumption (2017-2022)
-
10.5.6 Peru Gene Therapy in Oncology Consumption (2017-2022)
-
10.5.7 Puerto Rico Gene Therapy in Oncology Consumption (2017-2022)
-
10.5.8 Ecuador Gene Therapy in Oncology Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Gene Therapy in Oncology Consumption (2017-2022)
-
10.6.2 Kuwait Gene Therapy in Oncology Consumption (2017-2022)
-
10.6.3 Oman Gene Therapy in Oncology Consumption (2017-2022)
-
10.6.4 Qatar Gene Therapy in Oncology Consumption (2017-2022)
-
10.6.5 Saudi Arabia Gene Therapy in Oncology Consumption (2017-2022)
-
10.6.6 United Arab Emirates Gene Therapy in Oncology Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Gene Therapy in Oncology Consumption (2017-2022)
-
10.7.2 South Africa Gene Therapy in Oncology Consumption (2017-2022)
-
10.7.3 Egypt Gene Therapy in Oncology Consumption (2017-2022)
-
10.7.4 Algeria Gene Therapy in Oncology Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Gene Therapy in Oncology Consumption (2017-2022)
-
10.8.2 New Zealand Gene Therapy in Oncology Consumption (2017-2022)
11 Global Gene Therapy in Oncology Competitive Analysis
-
11.1 Shenzhen SiBiono GeneTech
-
11.1.1 Shenzhen SiBiono GeneTech Company Details
-
11.1.2 Shenzhen SiBiono GeneTech Gene Therapy in Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Shenzhen SiBiono GeneTech Gene Therapy in Oncology Main Business and Markets Served
-
11.1.4 Shenzhen SiBiono GeneTech Gene Therapy in Oncology Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Cold Genesys
-
11.2.1 Cold Genesys Company Details
-
11.2.2 Cold Genesys Gene Therapy in Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Cold Genesys Gene Therapy in Oncology Main Business and Markets Served
-
11.2.4 Cold Genesys Gene Therapy in Oncology Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Merck
-
11.3.1 Merck Company Details
-
11.3.2 Merck Gene Therapy in Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Merck Gene Therapy in Oncology Main Business and Markets Served
-
11.3.4 Merck Gene Therapy in Oncology Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Bio-Path Holdings
-
11.4.1 Bio-Path Holdings Company Details
-
11.4.2 Bio-Path Holdings Gene Therapy in Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Bio-Path Holdings Gene Therapy in Oncology Main Business and Markets Served
-
11.4.4 Bio-Path Holdings Gene Therapy in Oncology Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Marsala Biotech
-
11.5.1 Marsala Biotech Company Details
-
11.5.2 Marsala Biotech Gene Therapy in Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Marsala Biotech Gene Therapy in Oncology Main Business and Markets Served
-
11.5.4 Marsala Biotech Gene Therapy in Oncology Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Advantagene
-
11.6.1 Advantagene Company Details
-
11.6.2 Advantagene Gene Therapy in Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Advantagene Gene Therapy in Oncology Main Business and Markets Served
-
11.6.4 Advantagene Gene Therapy in Oncology Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Bristol-Myers Squibb
-
11.7.1 Bristol-Myers Squibb Company Details
-
11.7.2 Bristol-Myers Squibb Gene Therapy in Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Bristol-Myers Squibb Gene Therapy in Oncology Main Business and Markets Served
-
11.7.4 Bristol-Myers Squibb Gene Therapy in Oncology Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Ziopharm Oncology
-
11.8.1 Ziopharm Oncology Company Details
-
11.8.2 Ziopharm Oncology Gene Therapy in Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Ziopharm Oncology Gene Therapy in Oncology Main Business and Markets Served
-
11.8.4 Ziopharm Oncology Gene Therapy in Oncology Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 CRISPR Therapeutics
-
11.9.1 CRISPR Therapeutics Company Details
-
11.9.2 CRISPR Therapeutics Gene Therapy in Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 CRISPR Therapeutics Gene Therapy in Oncology Main Business and Markets Served
-
11.9.4 CRISPR Therapeutics Gene Therapy in Oncology Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 UniQure
-
11.10.1 UniQure Company Details
-
11.10.2 UniQure Gene Therapy in Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 UniQure Gene Therapy in Oncology Main Business and Markets Served
-
11.10.4 UniQure Gene Therapy in Oncology Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Tocagen
-
11.11.1 Tocagen Company Details
-
11.11.2 Tocagen Gene Therapy in Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Tocagen Gene Therapy in Oncology Main Business and Markets Served
-
11.11.4 Tocagen Gene Therapy in Oncology Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 Amgen
-
11.12.1 Amgen Company Details
-
11.12.2 Amgen Gene Therapy in Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 Amgen Gene Therapy in Oncology Main Business and Markets Served
-
11.12.4 Amgen Gene Therapy in Oncology Product Portfolio
-
11.12.5 Recent Research and Development Strategies
-
11.13 Idera Pharmaceuticals
-
11.13.1 Idera Pharmaceuticals Company Details
-
11.13.2 Idera Pharmaceuticals Gene Therapy in Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
11.13.3 Idera Pharmaceuticals Gene Therapy in Oncology Main Business and Markets Served
-
11.13.4 Idera Pharmaceuticals Gene Therapy in Oncology Product Portfolio
-
11.13.5 Recent Research and Development Strategies
-
11.14 Oncosec
-
11.14.1 Oncosec Company Details
-
11.14.2 Oncosec Gene Therapy in Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
11.14.3 Oncosec Gene Therapy in Oncology Main Business and Markets Served
-
11.14.4 Oncosec Gene Therapy in Oncology Product Portfolio
-
11.14.5 Recent Research and Development Strategies
-
11.15 Intellia Therapeutics
-
11.15.1 Intellia Therapeutics Company Details
-
11.15.2 Intellia Therapeutics Gene Therapy in Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
11.15.3 Intellia Therapeutics Gene Therapy in Oncology Main Business and Markets Served
-
11.15.4 Intellia Therapeutics Gene Therapy in Oncology Product Portfolio
-
11.15.5 Recent Research and Development Strategies
-
11.16 AstraZeneca
-
11.16.1 AstraZeneca Company Details
-
11.16.2 AstraZeneca Gene Therapy in Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
11.16.3 AstraZeneca Gene Therapy in Oncology Main Business and Markets Served
-
11.16.4 AstraZeneca Gene Therapy in Oncology Product Portfolio
-
11.16.5 Recent Research and Development Strategies
-
11.17 Sillajen Biotherapeutics
-
11.17.1 Sillajen Biotherapeutics Company Details
-
11.17.2 Sillajen Biotherapeutics Gene Therapy in Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
11.17.3 Sillajen Biotherapeutics Gene Therapy in Oncology Main Business and Markets Served
-
11.17.4 Sillajen Biotherapeutics Gene Therapy in Oncology Product Portfolio
-
11.17.5 Recent Research and Development Strategies
-
11.18 Oncolytics Biotech
-
11.18.1 Oncolytics Biotech Company Details
-
11.18.2 Oncolytics Biotech Gene Therapy in Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
11.18.3 Oncolytics Biotech Gene Therapy in Oncology Main Business and Markets Served
-
11.18.4 Oncolytics Biotech Gene Therapy in Oncology Product Portfolio
-
11.18.5 Recent Research and Development Strategies
-
11.19 Johnson & Johnson
-
11.19.1 Johnson & Johnson Company Details
-
11.19.2 Johnson & Johnson Gene Therapy in Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
11.19.3 Johnson & Johnson Gene Therapy in Oncology Main Business and Markets Served
-
11.19.4 Johnson & Johnson Gene Therapy in Oncology Product Portfolio
-
11.19.5 Recent Research and Development Strategies
-
11.20 Editas Medicine
-
11.20.1 Editas Medicine Company Details
-
11.20.2 Editas Medicine Gene Therapy in Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
11.20.3 Editas Medicine Gene Therapy in Oncology Main Business and Markets Served
-
11.20.4 Editas Medicine Gene Therapy in Oncology Product Portfolio
-
11.20.5 Recent Research and Development Strategies
-
11.21 Mologen AG
-
11.21.1 Mologen AG Company Details
-
11.21.2 Mologen AG Gene Therapy in Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
11.21.3 Mologen AG Gene Therapy in Oncology Main Business and Markets Served
-
11.21.4 Mologen AG Gene Therapy in Oncology Product Portfolio
-
11.21.5 Recent Research and Development Strategies
-
11.22 Oncotelic
-
11.22.1 Oncotelic Company Details
-
11.22.2 Oncotelic Gene Therapy in Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
11.22.3 Oncotelic Gene Therapy in Oncology Main Business and Markets Served
-
11.22.4 Oncotelic Gene Therapy in Oncology Product Portfolio
-
11.22.5 Recent Research and Development Strategies
-
11.23 Geron Corp
-
11.23.1 Geron Corp Company Details
-
11.23.2 Geron Corp Gene Therapy in Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
11.23.3 Geron Corp Gene Therapy in Oncology Main Business and Markets Served
-
11.23.4 Geron Corp Gene Therapy in Oncology Product Portfolio
-
11.23.5 Recent Research and Development Strategies
12 Global Gene Therapy in Oncology Market Outlook by Types and Applications to 2028
-
12.1 Global Gene Therapy in Oncology Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Ex Vivo Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global In Vivo Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Gene Therapy in Oncology Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Diagnostics Centers Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Research Institutes Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Gene Therapy in Oncology Market Analysis and Outlook to 2028
-
13.1 Global Gene Therapy in Oncology Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Gene Therapy in Oncology Consumption Forecast (2022-2028)
-
13.2.2 Canada Gene Therapy in Oncology Consumption Forecast (2022-2028)
-
13.2.3 Mexico Gene Therapy in Oncology Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Gene Therapy in Oncology Consumption Forecast (2022-2028)
-
13.3.2 UK Gene Therapy in Oncology Consumption Forecast (2022-2028)
-
13.3.3 Spain Gene Therapy in Oncology Consumption Forecast (2022-2028)
-
13.3.4 Belgium Gene Therapy in Oncology Consumption Forecast (2022-2028)
-
13.3.5 France Gene Therapy in Oncology Consumption Forecast (2022-2028)
-
13.3.6 Italy Gene Therapy in Oncology Consumption Forecast (2022-2028)
-
13.3.7 Denmark Gene Therapy in Oncology Consumption Forecast (2022-2028)
-
13.3.8 Finland Gene Therapy in Oncology Consumption Forecast (2022-2028)
-
13.3.9 Norway Gene Therapy in Oncology Consumption Forecast (2022-2028)
-
13.3.10 Sweden Gene Therapy in Oncology Consumption Forecast (2022-2028)
-
13.3.11 Poland Gene Therapy in Oncology Consumption Forecast (2022-2028)
-
13.3.12 Russia Gene Therapy in Oncology Consumption Forecast (2022-2028)
-
13.3.13 Turkey Gene Therapy in Oncology Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Gene Therapy in Oncology Consumption Forecast (2022-2028)
-
13.4.2 Japan Gene Therapy in Oncology Consumption Forecast (2022-2028)
-
13.4.3 India Gene Therapy in Oncology Consumption Forecast (2022-2028)
-
13.4.4 South Korea Gene Therapy in Oncology Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Gene Therapy in Oncology Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Gene Therapy in Oncology Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Gene Therapy in Oncology Consumption Forecast (2022-2028)
-
13.4.8 Thailand Gene Therapy in Oncology Consumption Forecast (2022-2028)
-
13.4.9 Singapore Gene Therapy in Oncology Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Gene Therapy in Oncology Consumption Forecast (2022-2028)
-
13.4.11 Philippines Gene Therapy in Oncology Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Gene Therapy in Oncology Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Gene Therapy in Oncology Consumption Forecast (2022-2028)
-
13.5.2 Colombia Gene Therapy in Oncology Consumption Forecast (2022-2028)
-
13.5.3 Chile Gene Therapy in Oncology Consumption Forecast (2022-2028)
-
13.5.4 Argentina Gene Therapy in Oncology Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Gene Therapy in Oncology Consumption Forecast (2022-2028)
-
13.5.6 Peru Gene Therapy in Oncology Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Gene Therapy in Oncology Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Gene Therapy in Oncology Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Gene Therapy in Oncology Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Gene Therapy in Oncology Consumption Forecast (2022-2028)
-
13.6.3 Oman Gene Therapy in Oncology Consumption Forecast (2022-2028)
-
13.6.4 Qatar Gene Therapy in Oncology Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Gene Therapy in Oncology Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Gene Therapy in Oncology Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Gene Therapy in Oncology Consumption Forecast (2022-2028)
-
13.7.2 South Africa Gene Therapy in Oncology Consumption Forecast (2022-2028)
-
13.7.3 Egypt Gene Therapy in Oncology Consumption Forecast (2022-2028)
-
13.7.4 Algeria Gene Therapy in Oncology Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Gene Therapy in Oncology Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Gene Therapy in Oncology Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Gene Therapy in Oncology
-
Figure of Gene Therapy in Oncology Picture
-
Table Global Gene Therapy in Oncology Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Gene Therapy in Oncology Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Ex Vivo Consumption and Growth Rate (2017-2022)
-
Figure Global In Vivo Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Diagnostics Centers Consumption and Growth Rate (2017-2022)
-
Figure Global Research Institutes Consumption and Growth Rate (2017-2022)
-
Figure Global Gene Therapy in Oncology Consumption by Country (2017-2022)
-
Table North America Gene Therapy in Oncology Consumption by Country (2017-2022)
-
Figure United States Gene Therapy in Oncology Consumption and Growth Rate (2017-2022)
-
Figure Canada Gene Therapy in Oncology Consumption and Growth Rate (2017-2022)
-
Figure Mexico Gene Therapy in Oncology Consumption and Growth Rate (2017-2022)
-
Table Europe Gene Therapy in Oncology Consumption by Country (2017-2022)
-
Figure Germany Gene Therapy in Oncology Consumption and Growth Rate (2017-2022)
-
Figure UK Gene Therapy in Oncology Consumption and Growth Rate (2017-2022)
-
Figure Spain Gene Therapy in Oncology Consumption and Growth Rate (2017-2022)
-
Figure Belgium Gene Therapy in Oncology Consumption and Growth Rate (2017-2022)
-
Figure France Gene Therapy in Oncology Consumption and Growth Rate (2017-2022)
-
Figure Italy Gene Therapy in Oncology Consumption and Growth Rate (2017-2022)
-
Figure Denmark Gene Therapy in Oncology Consumption and Growth Rate (2017-2022)
-
Figure Finland Gene Therapy in Oncology Consumption and Growth Rate (2017-2022)
-
Figure Norway Gene Therapy in Oncology Consumption and Growth Rate (2017-2022)
-
Figure Sweden Gene Therapy in Oncology Consumption and Growth Rate (2017-2022)
-
Figure Poland Gene Therapy in Oncology Consumption and Growth Rate (2017-2022)
-
Figure Russia Gene Therapy in Oncology Consumption and Growth Rate (2017-2022)
-
Figure Turkey Gene Therapy in Oncology Consumption and Growth Rate (2017-2022)
-
Table APAC Gene Therapy in Oncology Consumption by Country (2017-2022)
-
Figure China Gene Therapy in Oncology Consumption and Growth Rate (2017-2022)
-
Figure Japan Gene Therapy in Oncology Consumption and Growth Rate (2017-2022)
-
Figure India Gene Therapy in Oncology Consumption and Growth Rate (2017-2022)
-
Figure South Korea Gene Therapy in Oncology Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Gene Therapy in Oncology Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Gene Therapy in Oncology Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Gene Therapy in Oncology Consumption and Growth Rate (2017-2022)
-
Figure Thailand Gene Therapy in Oncology Consumption and Growth Rate (2017-2022)
-
Figure Singapore Gene Therapy in Oncology Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Gene Therapy in Oncology Consumption and Growth Rate (2017-2022)
-
Figure Philippines Gene Therapy in Oncology Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Gene Therapy in Oncology Consumption and Growth Rate (2017-2022)
-
Table South America Gene Therapy in Oncology Consumption by Country (2017-2022)
-
Figure Brazil Gene Therapy in Oncology Consumption and Growth Rate (2017-2022)
-
Figure Colombia Gene Therapy in Oncology Consumption and Growth Rate (2017-2022)
-
Figure Chile Gene Therapy in Oncology Consumption and Growth Rate (2017-2022)
-
Figure Argentina Gene Therapy in Oncology Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Gene Therapy in Oncology Consumption and Growth Rate (2017-2022)
-
Figure Peru Gene Therapy in Oncology Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Gene Therapy in Oncology Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Gene Therapy in Oncology Consumption and Growth Rate (2017-2022)
-
Table GCC Gene Therapy in Oncology Consumption by Country (2017-2022)
-
Figure Bahrain Gene Therapy in Oncology Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Gene Therapy in Oncology Consumption and Growth Rate (2017-2022)
-
Figure Oman Gene Therapy in Oncology Consumption and Growth Rate (2017-2022)
-
Figure Qatar Gene Therapy in Oncology Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Gene Therapy in Oncology Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Gene Therapy in Oncology Consumption and Growth Rate (2017-2022)
-
Table Africa Gene Therapy in Oncology Consumption by Country (2017-2022)
-
Figure Nigeria Gene Therapy in Oncology Consumption and Growth Rate (2017-2022)
-
Figure South Africa Gene Therapy in Oncology Consumption and Growth Rate (2017-2022)
-
Figure Egypt Gene Therapy in Oncology Consumption and Growth Rate (2017-2022)
-
Figure Algeria Gene Therapy in Oncology Consumption and Growth Rate (2017-2022)
-
Table Oceania Gene Therapy in Oncology Consumption by Country (2017-2022)
-
Figure Australia Gene Therapy in Oncology Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Gene Therapy in Oncology Consumption and Growth Rate (2017-2022)
-
Table Shenzhen SiBiono GeneTech Company Details
-
Table Shenzhen SiBiono GeneTech Gene Therapy in Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shenzhen SiBiono GeneTech Gene Therapy in Oncology Main Business and Markets Served
-
Table Shenzhen SiBiono GeneTech Gene Therapy in Oncology Product Portfolio
-
Table Cold Genesys Company Details
-
Table Cold Genesys Gene Therapy in Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cold Genesys Gene Therapy in Oncology Main Business and Markets Served
-
Table Cold Genesys Gene Therapy in Oncology Product Portfolio
-
Table Merck Company Details
-
Table Merck Gene Therapy in Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Gene Therapy in Oncology Main Business and Markets Served
-
Table Merck Gene Therapy in Oncology Product Portfolio
-
Table Bio-Path Holdings Company Details
-
Table Bio-Path Holdings Gene Therapy in Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bio-Path Holdings Gene Therapy in Oncology Main Business and Markets Served
-
Table Bio-Path Holdings Gene Therapy in Oncology Product Portfolio
-
Table Marsala Biotech Company Details
-
Table Marsala Biotech Gene Therapy in Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Marsala Biotech Gene Therapy in Oncology Main Business and Markets Served
-
Table Marsala Biotech Gene Therapy in Oncology Product Portfolio
-
Table Advantagene Company Details
-
Table Advantagene Gene Therapy in Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Advantagene Gene Therapy in Oncology Main Business and Markets Served
-
Table Advantagene Gene Therapy in Oncology Product Portfolio
-
Table Bristol-Myers Squibb Company Details
-
Table Bristol-Myers Squibb Gene Therapy in Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Gene Therapy in Oncology Main Business and Markets Served
-
Table Bristol-Myers Squibb Gene Therapy in Oncology Product Portfolio
-
Table Ziopharm Oncology Company Details
-
Table Ziopharm Oncology Gene Therapy in Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ziopharm Oncology Gene Therapy in Oncology Main Business and Markets Served
-
Table Ziopharm Oncology Gene Therapy in Oncology Product Portfolio
-
Table CRISPR Therapeutics Company Details
-
Table CRISPR Therapeutics Gene Therapy in Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
Table CRISPR Therapeutics Gene Therapy in Oncology Main Business and Markets Served
-
Table CRISPR Therapeutics Gene Therapy in Oncology Product Portfolio
-
Table UniQure Company Details
-
Table UniQure Gene Therapy in Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
Table UniQure Gene Therapy in Oncology Main Business and Markets Served
-
Table UniQure Gene Therapy in Oncology Product Portfolio
-
Table Tocagen Company Details
-
Table Tocagen Gene Therapy in Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Tocagen Gene Therapy in Oncology Main Business and Markets Served
-
Table Tocagen Gene Therapy in Oncology Product Portfolio
-
Table Amgen Company Details
-
Table Amgen Gene Therapy in Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Gene Therapy in Oncology Main Business and Markets Served
-
Table Amgen Gene Therapy in Oncology Product Portfolio
-
Table Idera Pharmaceuticals Company Details
-
Table Idera Pharmaceuticals Gene Therapy in Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Idera Pharmaceuticals Gene Therapy in Oncology Main Business and Markets Served
-
Table Idera Pharmaceuticals Gene Therapy in Oncology Product Portfolio
-
Table Oncosec Company Details
-
Table Oncosec Gene Therapy in Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Oncosec Gene Therapy in Oncology Main Business and Markets Served
-
Table Oncosec Gene Therapy in Oncology Product Portfolio
-
Table Intellia Therapeutics Company Details
-
Table Intellia Therapeutics Gene Therapy in Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Intellia Therapeutics Gene Therapy in Oncology Main Business and Markets Served
-
Table Intellia Therapeutics Gene Therapy in Oncology Product Portfolio
-
Table AstraZeneca Company Details
-
Table AstraZeneca Gene Therapy in Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Gene Therapy in Oncology Main Business and Markets Served
-
Table AstraZeneca Gene Therapy in Oncology Product Portfolio
-
Table Sillajen Biotherapeutics Company Details
-
Table Sillajen Biotherapeutics Gene Therapy in Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sillajen Biotherapeutics Gene Therapy in Oncology Main Business and Markets Served
-
Table Sillajen Biotherapeutics Gene Therapy in Oncology Product Portfolio
-
Table Oncolytics Biotech Company Details
-
Table Oncolytics Biotech Gene Therapy in Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Oncolytics Biotech Gene Therapy in Oncology Main Business and Markets Served
-
Table Oncolytics Biotech Gene Therapy in Oncology Product Portfolio
-
Table Johnson & Johnson Company Details
-
Table Johnson & Johnson Gene Therapy in Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Gene Therapy in Oncology Main Business and Markets Served
-
Table Johnson & Johnson Gene Therapy in Oncology Product Portfolio
-
Table Editas Medicine Company Details
-
Table Editas Medicine Gene Therapy in Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Editas Medicine Gene Therapy in Oncology Main Business and Markets Served
-
Table Editas Medicine Gene Therapy in Oncology Product Portfolio
-
Table Mologen AG Company Details
-
Table Mologen AG Gene Therapy in Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mologen AG Gene Therapy in Oncology Main Business and Markets Served
-
Table Mologen AG Gene Therapy in Oncology Product Portfolio
-
Table Oncotelic Company Details
-
Table Oncotelic Gene Therapy in Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Oncotelic Gene Therapy in Oncology Main Business and Markets Served
-
Table Oncotelic Gene Therapy in Oncology Product Portfolio
-
Table Geron Corp Company Details
-
Table Geron Corp Gene Therapy in Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Geron Corp Gene Therapy in Oncology Main Business and Markets Served
-
Table Geron Corp Gene Therapy in Oncology Product Portfolio
-
Figure Global Ex Vivo Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global In Vivo Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Diagnostics Centers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Research Institutes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Gene Therapy in Oncology Consumption Forecast by Country (2022-2028)
-
Table North America Gene Therapy in Oncology Consumption Forecast by Country (2022-2028)
-
Figure United States Gene Therapy in Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Gene Therapy in Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Gene Therapy in Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Gene Therapy in Oncology Consumption Forecast by Country (2022-2028)
-
Figure Germany Gene Therapy in Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Gene Therapy in Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Gene Therapy in Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Gene Therapy in Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Gene Therapy in Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Gene Therapy in Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Gene Therapy in Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Gene Therapy in Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Gene Therapy in Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Gene Therapy in Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Gene Therapy in Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Gene Therapy in Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Gene Therapy in Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Gene Therapy in Oncology Consumption Forecast by Country (2022-2028)
-
Figure China Gene Therapy in Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Gene Therapy in Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Gene Therapy in Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Gene Therapy in Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Gene Therapy in Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Gene Therapy in Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Gene Therapy in Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Gene Therapy in Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Gene Therapy in Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Gene Therapy in Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Gene Therapy in Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Gene Therapy in Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Gene Therapy in Oncology Consumption Forecast by Country (2022-2028)
-
Figure Brazil Gene Therapy in Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Gene Therapy in Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Gene Therapy in Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Gene Therapy in Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Gene Therapy in Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Gene Therapy in Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Gene Therapy in Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Gene Therapy in Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Gene Therapy in Oncology Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Gene Therapy in Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Gene Therapy in Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Gene Therapy in Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Gene Therapy in Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Gene Therapy in Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Gene Therapy in Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Gene Therapy in Oncology Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Gene Therapy in Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Gene Therapy in Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Gene Therapy in Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Gene Therapy in Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Gene Therapy in Oncology Consumption Forecast by Country (2022-2028)
-
Figure Australia Gene Therapy in Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Gene Therapy in Oncology Consumption Forecast and Growth Rate (2022-2028)
-
